REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPHW and the CUSIP is 76152G118. A total of 8 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,104 | -57.2% | 33,718 | 0.0% | 0.00% | – |
| Q1 2024 | $21,263 | -55.9% | 33,718 | 0.0% | 0.00% | – |
| Q4 2023 | $48,217 | -7.1% | 33,718 | 0.0% | 0.00% | – |
| Q3 2023 | $51,926 | -13.0% | 33,718 | 0.0% | 0.00% | – |
| Q2 2023 | $59,715 | +9.9% | 33,718 | -37.9% | 0.00% | -100.0% |
| Q1 2023 | $54,316 | +1.0% | 54,316 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $53,773 | +216.3% | 54,316 | -39.4% | 0.00% | – |
| Q3 2022 | $17,000 | +6.2% | 89,623 | 0.0% | 0.00% | – |
| Q2 2022 | $16,000 | -33.3% | 89,623 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $24,000 | -22.6% | 89,623 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $31,000 | -13.9% | 89,623 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $36,000 | -20.0% | 89,623 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $45,000 | +50.0% | 89,623 | +38.0% | 0.00% | 0.0% |
| Q1 2021 | $30,000 | -31.8% | 64,959 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $44,000 | – | 64,959 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arena Investors LP | 85,000 | $21,250 | 0.17% |
| Walleye Capital LLC | 33,718 | $9,104 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Walleye Trading LLC | 25,727 | $6,946 | 0.00% |
| UBS Group AG | 4,661 | $1,258 | 0.00% |